Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Healthcare CRO Services Market, by Service Type
1.4.2 Europe Healthcare CRO Services Market, by End User
1.4.3 Europe Healthcare CRO Services Market, by Therapeutic Area
1.4.4 Europe Healthcare CRO Services Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Aug – 2020, Mar) Leading Players
Chapter 4. Europe Healthcare CRO Services Market by Service Type
4.1 Europe Clinical Research Services Market by Country
4.2 Europe Early Phase Development Market by Country
4.3 Europe Laboratory Services Market by Country
4.4 Europe Consulting Services Market by Country
Chapter 5. Europe Healthcare CRO Services Market by End User
5.1 Europe Pharmaceutical Sector Market by Country
5.2 Europe Medical Device Sector Market by Country
5.3 Europe Academic Institutes Market by Country
Chapter 6. Europe Healthcare CRO Services Market by Therapeutic Areas
6.1 Europe Oncology Market by Country
6.2 Europe CNS Disorder Market by Country
6.3 Europe Cardiovascular Disease Market by Country
6.4 Europe Diabetes Market by Country
6.5 Europe Metabolic Diseases Market by Country
6.6 Europe Infectious Diseases Market by Country
6.7 Europe Other therapeutic areas Market by Country
Chapter 7. Europe Healthcare CRO Services Market by Country
7.1 Germany Healthcare CRO Services Market
7.1.1 Germany Healthcare CRO Services Market by Service Type
7.1.2 Germany Healthcare CRO Services Market by End User
7.1.3 Germany Healthcare CRO Services Market by Therapeutic Areas
7.2 UK Healthcare CRO Services Market
7.2.1 UK Healthcare CRO Services Market by Service Type
7.2.2 UK Healthcare CRO Services Market by End User
7.2.3 UK Healthcare CRO Services Market by Therapeutic Areas
7.3 France Healthcare CRO Services Market
7.3.1 France Healthcare CRO Services Market by Service Type
7.3.2 France Healthcare CRO Services Market by End User
7.3.3 France Healthcare CRO Services Market by Therapeutic Areas
7.4 Russia Healthcare CRO Services Market
7.4.1 Russia Healthcare CRO Services Market by Service Type
7.4.2 Russia Healthcare CRO Services Market by End User
7.4.3 Russia Healthcare CRO Services Market by Therapeutic Areas
7.5 Spain Healthcare CRO Services Market
7.5.1 Spain Healthcare CRO Services Market by Service Type
7.5.2 Spain Healthcare CRO Services Market by End User
7.5.3 Spain Healthcare CRO Services Market by Therapeutic Areas
7.6 Italy Healthcare CRO Services Market
7.6.1 Italy Healthcare CRO Services Market by Service Type
7.6.2 Italy Healthcare CRO Services Market by End User
7.6.3 Italy Healthcare CRO Services Market by Therapeutic Areas
7.7 Rest of Europe Healthcare CRO Services Market
7.7.1 Rest of Europe Healthcare CRO Services Market by Service Type
7.7.2 Rest of Europe Healthcare CRO Services Market by End User
7.7.3 Rest of Europe Healthcare CRO Services Market by Therapeutic Areas
Chapter 8. Company Profiles
8.1 IQVIA Holdings, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Recent strategies and developments:
8.1.4.1 Product Launches and Product Expansions:
8.2 Laboratory Corporation of America Holdings (Covance, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.1 Recent strategies and developments:
8.2.1.1 Product Launches and Product Expansions:
8.2.1.2 Acquisition and Mergers:
8.2.1.3 Geographical Expansions:
8.3 Pharmaceutical Product Development, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Recent strategies and developments:
8.3.4.1 Geographical Expansions:
8.3.4.2 Acquisition and Mergers:
8.3.4.3 Partnerships, Collaborations, and Agreements:
8.4 Parexel International Corporation (Pamplona Capital Management)
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Acquisition and Mergers:
8.4.2.2 Partnerships, Collaborations, and Agreements:
8.5 Charles River Laboratories International, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Acquisition and Mergers:
8.5.4.2 Partnerships, Collaborations, and Agreements:
8.6 ICON PLC
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Product Launches and Product Expansions:
8.6.4.2 Acquisition and Mergers:
8.6.4.3 Partnerships, Collaborations, and Agreements:
8.7 Dassault Systemes SE (Medidata Solutions, Inc.)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Syneos Health, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Recent strategies and developments:
8.8.4.1 Partnerships, Collaborations, and Agreements:
8.9 Pharmaron Beijing Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.1 GVK Biosciences Private Limited
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 